{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:08:59Z","timestamp":1794244139517,"version":"4.9.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.neuropharm.2024.110158","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T22:11:27Z","timestamp":1726179087000},"page":"110158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Alpha-asarone alleviates cutaneous hyperalgesia by inhibiting hyperexcitability and neurogenic inflammation via TLR4\/NF-\u03baB\/NLRP3 signaling pathway in a female chronic migraine rat model"],"prefix":"10.1016","volume":"261","author":[{"given":"Qi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110158_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1517\/13543780902913792","article-title":"Therapeutic potential of novel glutamate receptor antagonists in migraine","volume":"18","author":"Andreou","year":"2009","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.neuropharm.2024.110158_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2024.110158_bib3","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.pain.2014.03.001","article-title":"General trigeminospinal central sensitization and impaired descending pain inhibitory controls contribute to migraine progression","volume":"155","author":"Boyer","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2024.110158_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fncel.2016.00280","article-title":"Neurogenesis-promoting natural product \u03b1-asarone modulates morphological dynamics of activated microglia","volume":"10","author":"Cai","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110158_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuropharm.2019.107843","article-title":"Alpha-asarone improves cognitive function of aged rats by alleviating neuronal excitotoxicity via GABAA receptors","volume":"162","author":"Chen","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110158_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ejp.534","article-title":"Spinal toll-like receptor 4-mediated signalling pathway contributes to visceral hypersensitivity induced by neonatal colonic irritation in rats","volume":"19","author":"Chen","year":"2015","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2024.110158_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11916-011-0231-1","article-title":"Cortical excitability in chronic migraine","volume":"16","author":"Coppola","year":"2012","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.neuropharm.2024.110158_bib9","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.clinph.2011.02.013","article-title":"Exacerbated attention orienting to auditory stimulation in migraine patients","volume":"122","author":"Demarquay","year":"2011","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2024.110158_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/17448069211059400","article-title":"Neurokinins and their receptors in the rat trigeminal system: differential localization and release with implications for migraine pain","volume":"17","author":"Edvinsson","year":"2021","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2024.110158_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/head.13081","article-title":"The trigeminovascular pathway: role of CGRP and CGRP receptors in migraine","volume":"57","author":"Edvinsson","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.neuropharm.2024.110158_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41582-019-0216-y","article-title":"Does inflammation have a role in migraine?","volume":"15","author":"Edvinsson","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110158_bib13","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/brain\/aws225","article-title":"Neurological perspectives on voltage-gated sodium channels","volume":"135","author":"Eijkelkamp","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2024.110158_bib14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1080\/13543784.2017.1395411","article-title":"Glutamate receptor antagonists with the potential for migraine treatment","volume":"26","author":"Ferrari","year":"2017","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.neuropharm.2024.110158_bib15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1177\/0333102417703764","article-title":"Region-specific disruption of the blood-brain barrier following repeated inflammatory dural stimulation in a rat model of chronic trigeminal allodynia","volume":"38","author":"Fried","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2024.110158_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.phymed.2022.154363","article-title":"Alpha-asarone ameliorates neurological deterioration of intracerebral hemorrhagic rats by alleviating secondary brain injury via anti-excitotoxicity pathways","volume":"105","author":"Gao","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2024.110158_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.biochem.76.060305.151318","article-title":"Structure and function of toll receptors and their Ligands","volume":"76","author":"Gay","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2024.110158_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1213\/ANE.0000000000002792","article-title":"\u03b1-Asarone alleviated chronic constriction injury-induced neuropathic pain through inhibition of spinal endoplasmic reticulum stress in a liver X receptor-dependent manner","volume":"127","author":"Gui","year":"2018","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2024.110158_bib19","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1089\/neu.2006.23.1111","article-title":"Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury","volume":"23","author":"Gwak","year":"2006","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neuropharm.2024.110158_bib20","first-page":"R73","article-title":"The AMPA receptor subunits GluR-A and GluR-B reciprocally modulate spinal synaptic plasticity and inflammatory pain","volume":"371","author":"Hartmann","year":"2005","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110158_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s13311-018-0616-5","article-title":"Glutamate and its receptors as therapeutic targets for migraine","volume":"15","author":"Hoffmann","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2024.110158_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s10194-017-0758-6","article-title":"Duration and frequency of migraines affect cognitive function: evidence from neuropsychological tests and event-related potentials","volume":"18","author":"Huang","year":"2017","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.neuropharm.2024.110158_bib23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","article-title":"Neuroinflammation and central sensitization in chronic and widespread pain","volume":"129","author":"Ji","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2024.110158_bib24","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbrc.2013.12.039","article-title":"TLR4-dependent metabolic changes are associated with cognitive impairment in an animal model of type 1 diabetes","volume":"443","author":"Kawamoto","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2024.110158_bib25","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1523\/JNEUROSCI.3338-07.2008","article-title":"Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1\u03b2, interleukin-6, and tumor necrosis factor-\u03b2 in regulating synaptic and neuronal activity in the superficial spinal cord","volume":"28","author":"Kawasaki","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110158_bib26","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1038\/emboj.2012.161","article-title":"Impairment of GABAB receptor dimer by endogenous 14-3-3\u03b6 in chronic pain conditions","volume":"31","author":"Laffray","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2024.110158_bib27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","article-title":"Central sensitization: a generator of pain hypersensitivity by central neural plasticity","volume":"10","author":"Latremoliere","year":"2009","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2024.110158_bib28","article-title":"The relationship between TLR4\/NF-\u03baB\/IL-1\u03b2 signaling, cognitive impairment, and white-matter integrity in patients with stable chronic schizophrenia","volume":"13","author":"Li","year":"2022","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110158_bib29","first-page":"14","article-title":"Toll-like receptor 4 signaling in neurons of trigeminal ganglion contributes to nociception induced by acute pulpitis in rats","volume":"5","author":"Lin","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2024.110158_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3389\/fneur.2017.00661","article-title":"\u03b1-asarone attenuates cognitive Deficit in a Pilocarpine-induced status epilepticus rat Model via a Decrease in the nuclear Factor-\u03baB activation and reduction in Microglia neuroinflammation","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110158_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","article-title":"Chronic migraine: risk factors, mechanisms and treatment","volume":"12","author":"May","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110158_bib32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/neu.2009.1166","article-title":"Loss of GABAergic interneurons in laminae I-iii of the spinal cord dorsal horn contributes to reduced GABAergic tone and neuropathic pain after spinal cord injury","volume":"27","author":"Meisner","year":"2010","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neuropharm.2024.110158_bib33","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1038\/s41380-021-01085-2","article-title":"Neural correlates of visuospatial processing in migraine: does the pain network help?","volume":"26","author":"Messina","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110158_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153905","article-title":"Wuzhuyu Decoction relieves hyperalgesia by regulating central and peripheral 5-HT in chronic migraine model rats","volume":"96","author":"Nan","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2024.110158_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gene.2011.08.031","article-title":"Significant differences in gene expression of GABA receptors in peripheral blood leukocytes of migraineurs","volume":"490","author":"Plummer","year":"2011","journal-title":"Gene"},{"key":"10.1016\/j.neuropharm.2024.110158_bib36","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1038\/s41380-020-00971-5","article-title":"AIM2 inflammasome mediates hallmark neuropathological alterations and cognitive impairment in a mouse model of vascular dementia","volume":"26","author":"Poh","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.110158_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1371\/journal.pone.0074087","article-title":"Interaction between \u03b3-aminobutyric acid A receptor genes: new evidence in migraine susceptibility","volume":"8","author":"Quintas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110158_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1096\/fj.06-6163com","article-title":"Protein kinase C activity blocks neuropeptide Y-mediated inhibition of glutamate release and contributes to excitability of the hippocampus in status epilepticus","volume":"21","author":"Silva","year":"2007","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2024.110158_bib39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1744806918754612","article-title":"Inhibition of toll-like receptor 4 alleviates hyperalgesia induced by acute dural inflammation in experimental migraine","volume":"14","author":"Su","year":"2018","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2024.110158_bib40","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1111\/ejn.13296","article-title":"Rizatriptan overuse promotes hyperalgesia induced by dural inflammatory stimulation in rats by modulation of the serotonin system","volume":"44","author":"Su","year":"2016","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110158_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s10194-020-01185-4","article-title":"My Migraine Voice survey: disease impact on healthcare resource utilization, personal and working life in Finland","volume":"21","author":"Sumelahti","year":"2020","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.neuropharm.2024.110158_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s10194-022-01442-8","article-title":"P2X7R\/NLRP3 signaling pathway-mediated pyroptosis and neuroinflammation contributed to cognitive impairment in a mouse model of migraine","volume":"23","author":"Wang","year":"2022","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.neuropharm.2024.110158_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fphar.2014.00040","article-title":"Identification of both GABAA receptors and voltage-activated Na+ channels as molecular targets of anticonvulsant \u03b1-asarone","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110158_bib44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tips.2009.08.002","article-title":"The \"toll\" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia","volume":"30","author":"Watkins","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110158_bib45","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1097\/j.pain.0000000000000615","article-title":"Insular balance of glutamatergic and GABAergic signaling modulates pain processing","volume":"157","author":"Watson","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2024.110158_bib46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbi.2016.03.026","article-title":"Systemic TAK-242 prevents intrathecal LPS evoked hyperalgesia in male, but not female mice and prevents delayed allodynia following intraplantar formalin in both male and female mice: the role of TLR4 in the evolution of a persistent pain state","volume":"56","author":"Woller","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2024.110158_bib47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuroscience.2020.12.026","article-title":"Alpha-asarone improves cognitive function of APP\/PS1 mice and reducing A\u03b242, P-tau and neuroinflammation, and promoting neuron survival in the Hippocampus","volume":"458","author":"Zeng","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110158_bib48","doi-asserted-by":"crossref","first-page":"14780","DOI":"10.1096\/fj.202001561R","article-title":"Deficiency in the function of inhibitory interneurons contributes to glutamate-associated central sensitization through GABABR2-SynCAM1 signaling in chronic migraine rats","volume":"34","author":"Zeng","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2024.110158_bib49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2021.08.006","article-title":"Neuroprotective effect of alpha-asarone on the rats model of cerebral ischemia-reperfusion stroke via ameliorating glial activation and autophagy","volume":"473","author":"Zhang","year":"2021","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2024.110158_bib50","first-page":"11202","article-title":"Analgesic effect of TAK-242 on neuropathic pain in rats","volume":"8","author":"Zhao","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.neuropharm.2024.110158_bib51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/jnc.14944","article-title":"Up-regulation of astrocyte excitatory amino acid transporter 2 alleviates central sensitization in a rat model of chronic migraine","volume":"155","author":"Zhou","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110158_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-2094-11-59","article-title":"Curcumin attenuates acute inflammatory injury by inhibiting the TLR4\/MyD88\/NF-\u03baB signaling pathway in experimental traumatic brain injury","volume":"11","author":"Zhu","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2024.110158_bib53","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.2147\/JPR.S327945","article-title":"Alterations in effective connectivity of the hippocampus in migraine without Aura","volume":"14","author":"Zhu","year":"2021","journal-title":"J. Pain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T03:57:17Z","timestamp":1730865437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824003277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":52,"alternative-id":["S0028390824003277"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110158","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-asarone alleviates cutaneous hyperalgesia by inhibiting hyperexcitability and neurogenic inflammation via TLR4\/NF-\u03baB\/NLRP3 signaling pathway in a female chronic migraine rat model","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110158"}}